Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study

Código QR

Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study

Ahmed AK Hassoun,1 Md Faruque Pathan,2 Rita C Medlej,3,4 Monira Alarouj,5 Inass Shaltout,6 Manoj S Chawla,7 Ditte Knap,8 Julius A Vaz9 1Dubai Diabetes Centre, Dubai, UAE; 2Department of Endocrinology, BIRDEM Hospital, Dhaka, Bangladesh; 3Department of Endocrinology, Hotel Dieu de France Hospital, 4C...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hassoun AAK, Pathan MF, Medlej RC, Alarouj M, Shaltout I, Chawla MS, Knap D, Vaz JA
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	age metformin Ramadan sulfonylurea type 2 diabetes vildagliptin Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/143b0bf2343345a18b60407c25bca396
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The diabetic patient in Ramadan
por: Hassan Chamsi-Pasha, et al.
Publicado: (2014)

Metformin-Insulin versus Metformin-Sulfonylurea Combination Therapies in Type 2 Diabetes: A Comparative Study of Glycemic Control and Risk of Cardiovascular Diseases in Addis Ababa, Ethiopia
por: Gebrie D, et al.
Publicado: (2021)

Beta-cell function in type 2 diabetic patients who failed to maintain good glycemic status with a combination of maximum dosages of metformin and sulfonylurea
por: Kunavisarut T, et al.
Publicado: (2019)

The cardiac patient in Ramadan
por: Majed Chamsi Pasha, et al.
Publicado: (2016)

Ramadan Fasting, Health, and Autophagy: Is There any Relationship?
por: Taufiqurrachman Nasihun
Publicado: (2018)

Muslim patients in Ramadan: A review for primary care physicians
por: Heba Abolaban, et al.
Publicado: (2017)

Running Performance during the Holy Month of Ramadan in Elite Professional Adult Soccer Players in Russia
por: Eduard Bezuglov, et al.
Publicado: (2021)

Results of a clinical trial of the efficacy and safety of vildagliptin and metformin fixed combination in real clinical practice in Russia (MASTER study)
por: N. A. Demidov, et al.
Publicado: (2021)

Vildagliptin: the first innovative DDP-4 inhibitor
por: Edvin Villkhauer
Publicado: (2010)

Hukum Membuka Tempat Makan Pada Siang Ramadan (Analisis Hukum Islam Dengan Pendekatan Usuliyah)
por: Imamul Muttaqin
Publicado: (2021)

Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Soon-Jib Yoo, et al.
Publicado: (2021)

Clinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications
por: Elena Valer'evna Biryukova
Publicado: (2014)

Sulfonylureas and cardiovascular complications of type 2 diabetes mellitus
por: Lyudmila Viktorovna Nedosugova
Publicado: (2013)

Nanofibrous vildagliptin-eluting stents enhance re-endothelialization and reduce neointimal formation in diabetes: in vitro and in vivo
por: Lee CH, et al.
Publicado: (2019)

DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHODS FOR THE DETERMINATION AND SPECTROSCOPIC CHARACTERIZATION OF VILDAGLIPTIN USING II -ACCEPTORS IN PHARMACEUTICAL PREPARATIONS
por: TEKKELI,SERIFE EVRIM KEPEKCI, et al.
Publicado: (2014)

Diabetes During the Fasting Month of Ramadan: Is Telemedicine as Efficient as Conventional Follow-Up? Results from a Moroccan Comparative Study
por: Motaib I, et al.
Publicado: (2021)

Pharmacoeconomic aspects of the use of sulfonylurea drugs in type 2 diabetes mellitus
por: Alla Vsevolodovna Rudakova
Publicado: (2011)

Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies
por: Natthida Sriboonvorakul, et al.
Publicado: (2021)

EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus
por: Gagik Radikovich Galstyan
Publicado: (2013)

To fast or not to fast during the month of Ramadan? A comprehensive survey on religious beliefs and practices among Moroccan diabetic patients
por: Al-Balhan E, et al.
Publicado: (2018)

Vildagliptin: optimal control in type 2 diabetes mellitus treatment
por: Alexander Sergeevich Ametov
Publicado: (2015)

Feasibility of efficacious therapy of diabetes mellitus by sulfonylurea agents in neonates with KCNJII gene mutation: originalobservation
por: Andrey Olegovich Emel'yanov, et al.
Publicado: (2009)

Risk of oncological diseases in patients with diabetes mellitus
por: Gagik Radikovich Galstyan
Publicado: (2009)

The frequency of hypoglycemia and cardiovascular disorders during therapy with sulfonylureas compared with other secretagogues: a systematic review
por: Aleksey Vadimovich Zilov, et al.
Publicado: (2010)

What are new opportunities for clinical practice the VERIFY study opens and which values for native diabetes patients? Joint conclusion on the advisory board results. November 6, 2019
por: Marina V. Shestakova, et al.
Publicado: (2020)

Sulfonylurea Receptor 1 in Central Nervous System Injury: An Updated Review
por: Ruchira M. Jha, et al.
Publicado: (2021)

Knowledge, Attitude and Practice Regarding Ramadan Fasting and Related Determinants in Patients with Type 2 Diabetes at a Saudi Diabetes Clinic
por: Alsunni AA, et al.
Publicado: (2020)

MOROCCAN YOUTH’S CONSUMPTION OF TV PROGRAMS DURING RAMADAN AND CHANGES OF THE DIGITAL ERA
por: ACHRAF DADOUH, et al.
Publicado: (2020)

First Russian DPP-4 inhibitor Gosogliptin comparing to Vildagliptin in type 2 diabetes mellitus patients
por: Karina Oganesovna Galstyan, et al.
Publicado: (2016)

Metformin Induces Ultrastructural Alterations in Hepatocytes of Spontaneously Hypertensive Rats
por: Gharbaran,Rajendra
Publicado: (2014)

Effects of Mental Training Through Imagery on the Competitive Anxiety of Adolescent Tennis Players Fasting During Ramadan: A Randomized, Controlled Experimental Study
por: Sofien Fekih, et al.
Publicado: (2021)

Self-Monitoring of Blood Glucose and Hypoglycemia Association During Fasting in Ramadan Among Patients with Diabetes
por: Mansouri D, et al.
Publicado: (2020)

Fasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients
por: Aziz KMA
Publicado: (2015)

Integrated effects of herbicides and foliar fertilizer on corn inbred line
por: Brankov,Milan, et al.
Publicado: (2020)

DEVELOPMENT, COMPUTATIONAL STUDIES AND VALIDATION OF SPECTROPHOTOMETRIC METHOD OF METFORMIN HYDROCHLORIDE IN PHARMACEUTICAL FORMULATIONS
por: Judeh,Ahmed Abu, et al.
Publicado: (2020)

Metformin Protects Against Thioacetamide Induced Liver injury in Rats
por: Al-Hashem,Fahaid, et al.
Publicado: (2018)

Metformin Pretreatment Ameliorates Diabetic Nephropathy Induced by a Combination of High Fat Diet and Streptozotocin in Rats
por: Dallak,Mohammad, et al.
Publicado: (2018)

Metformin and cancer mortality
por: Lev Mikhaylovich Bershteyn
Publicado: (2010)

Initial glucose-lowering therapy and risks of overall and cardiovascular mortality, myocardial infarction and stroke in patients with type2 diabetes
por: Inna Vladimirovna Misnikova, et al.
Publicado: (2009)

Type 2 diabetes therapy at the time of diagnosis. Glimepiride: property, efficiency, safety
por: Olga Mikhailovna Smirnova
Publicado: (2009)